269 related articles for article (PubMed ID: 21518950)
1. Enforcement actions involving Medicaid fraud and abuse, 1996-2009.
Qureshi ZP; Liu Y; Sartor O; Chu YH; Bennett CL
Arch Intern Med; 2011 Apr; 171(8):785-7. PubMed ID: 21518950
[No Abstract] [Full Text] [Related]
2. Pharmaceuticals and Medical Devices: Business Practices.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-38. PubMed ID: 28252886
[No Abstract] [Full Text] [Related]
3. Four US drug companies pay $124m for defrauding Medicaid.
Tanne JH
BMJ; 2009 Oct; 339():b4500. PubMed ID: 19875428
[No Abstract] [Full Text] [Related]
4. Pharmaceutical fraud and abuse in the United States, 1996-2010.
Qureshi ZP; Sartor O; Xirasagar S; Liu Y; Bennett CL
Arch Intern Med; 2011 Sep; 171(16):1503-6. PubMed ID: 21911639
[No Abstract] [Full Text] [Related]
5. Medicaid reimbursement. Issue brief.
Berry MD
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-29. PubMed ID: 23297437
[No Abstract] [Full Text] [Related]
6. Some legal and managerial strategies for managing healthcare fraud.
Paul RJ; Townsend JB
Health Mark Q; 1997; 14(3):19-33. PubMed ID: 10167310
[TBL] [Abstract][Full Text] [Related]
7. Fighting fraud: Medicaid. States are sniffing out Medicaid swindlers and saving a lot of money.
Comlossy M
State Legis; 2013 Apr; 39(4):14-7. PubMed ID: 23565570
[No Abstract] [Full Text] [Related]
8. A discussion of pharmaceutical industry practices viewed as illegal by the federal government.
Nino K
Health Care Law Mon; 1999 Nov; ():8-16. PubMed ID: 11067433
[No Abstract] [Full Text] [Related]
9. Targeting drug companies' bottom line.
Prescrire Int; 2011 Jan; 20(112):25. PubMed ID: 21462792
[No Abstract] [Full Text] [Related]
10. Government investigations in the pharmaceutical industry: off-label promotion, fraud and abuse, and false claims.
Kalb PE; Bass IS
Food Drug Law J; 1998; 53(1):63-70. PubMed ID: 11795337
[No Abstract] [Full Text] [Related]
11. Perversities--beware of being 'sucked in'.
Bateman C
S Afr Med J; 2009 Apr; 99(4):210, 212. PubMed ID: 19588767
[No Abstract] [Full Text] [Related]
12. Healthcare reform enforcement and compliance.
Berry MD
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-37. PubMed ID: 24645220
[No Abstract] [Full Text] [Related]
13. Recent developments in false claims enforcement: a minefield for health care providers.
Whitaker GV; Walton VA
J Health Care Finance; 2007; 33(3):17-21. PubMed ID: 19175229
[TBL] [Abstract][Full Text] [Related]
14. US drug companies paid $15bn in fines for fraudulent marketing in past five years.
Tanne JH
BMJ; 2010 Dec; 341():c7360. PubMed ID: 21177361
[No Abstract] [Full Text] [Related]
15. ANTI-FRAUD FERVOR: STATES STEP UP FALSE CLAIMS ACTIONS TO RECOVER MEDICAID DOLLARS.
Schencker L
Mod Healthc; 2015 Jul; 45(30):20-2. PubMed ID: 26510279
[No Abstract] [Full Text] [Related]
16. Medicaid program integrity: fighting fraud, waste, and abuse.
Comlossy M
NCSL Legisbrief; 2013 Feb; 21(7):1-2. PubMed ID: 23581027
[No Abstract] [Full Text] [Related]
17. Pharmaceuticals and Medical Devices: Business Practices.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2015 Dec; ():1-37. PubMed ID: 27116796
[No Abstract] [Full Text] [Related]
18. Medicaid reimbursement.
Berry MD
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-31. PubMed ID: 18345577
[No Abstract] [Full Text] [Related]
19. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
Roehr B
BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
[No Abstract] [Full Text] [Related]
20. New law stiffens penalties for fraud and abuse and sets up advisory opinion process.
Kannensohn K
Benders Health Care Law Mon; 1996 Sep; ():11-3. PubMed ID: 10162256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
